The major cause of mortality and morbidity due to cardiovascular disease.
Here at De Winther Lab, we’re committed to investing our expertise and resources in order to achieve our goals. Since 2000, we’ve been studying in a variety of ways what processes control atherosclerosis development. We have identified signaling pathways, lipid mediators, epigenetic molecules and cellular phenotypes that impact on monocytes and macrophages, atherosclerotic disease development, plaque stability and clinical relevant parameters. Just imagine what we can achieve together!